Literature DB >> 33434065

Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies.

Steven M Devine1,2, Mary M Horowitz3,4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33434065      PMCID： PMC8443822          DOI： 10.1200/JCO.20.01623

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  79 in total

1.  CAR T cell therapy: inroads to response and resistance.

Authors:  Christine E Brown; Crystal L Mackall
Journal:  Nat Rev Immunol       Date:  2019-02       Impact factor: 53.106

2.  Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Authors:  Merry Jennifer Markham; Kerri Wachter; Neeraj Agarwal; Monica M Bertagnolli; Susan Marina Chang; William Dale; Catherine S M Diefenbach; Carlos Rodriguez-Galindo; Daniel J George; Timothy D Gilligan; R Donald Harvey; Melissa L Johnson; Randall J Kimple; Miriam A Knoll; Noelle LoConte; Robert G Maki; Jane Lowe Meisel; Jeffrey A Meyerhardt; Nathan A Pennell; Gabrielle B Rocque; Michael S Sabel; Richard L Schilsky; Bryan James Schneider; William D Tap; Robert G Uzzo; Shannon Neville Westin
Journal:  J Clin Oncol       Date:  2020-02-04       Impact factor: 44.544

3.  Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy.

Authors:  Mazyar Shadman; Jordan Gauthier; Kevin A Hay; Jenna M Voutsinas; Filippo Milano; Ang Li; Alexandre V Hirayama; Mohamed L Sorror; Sindhu Cherian; Xueyan Chen; Ryan D Cassaday; Brian G Till; Ajay K Gopal; Brenda M Sandmaier; David G Maloney; Cameron J Turtle
Journal:  Blood Adv       Date:  2019-10-22

4.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Authors:  P L Weiden; N Flournoy; E D Thomas; R Prentice; A Fefer; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

5.  Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303.

Authors:  Steven M Devine; Shelly Carter; Robert J Soiffer; Marcelo C Pasquini; Parameswaran N Hari; Anthony Stein; Hillard M Lazarus; Charles Linker; Edward A Stadtmauer; Edwin P Alyea; Carolyn A Keever-Taylor; Richard J O'Reilly
Journal:  Biol Blood Marrow Transplant       Date:  2011-02-12       Impact factor: 5.742

6.  Retooling institutional support infrastructure for clinical research.

Authors:  Denise C Snyder; Rebecca N Brouwer; Cory L Ennis; Lindsey L Spangler; Terry L Ainsworth; Susan Budinger; Catherine Mullen; Jeffrey Hawley; Gina Uhlenbrauck; Mark Stacy
Journal:  Contemp Clin Trials       Date:  2016-04-26       Impact factor: 2.226

7.  Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.

Authors:  David M Waterhouse; R Donald Harvey; Patricia Hurley; Laura A Levit; Edward S Kim; Heidi D Klepin; Kathryn Finch Mileham; Grzegorz Nowakowski; Caroline Schenkel; Courtney Davis; Suanna S Bruinooge; Richard L Schilsky
Journal:  JCO Oncol Pract       Date:  2020-05-12

8.  PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.

Authors:  Bronwen E Shaw; Karen L Syrjala; Lynn E Onstad; Eric J Chow; Mary E Flowers; Heather Jim; K Scott Baker; Sarah Buckley; Diane L Fairclough; Mary M Horowitz; Stephanie J Lee
Journal:  Cancer       Date:  2017-10-26       Impact factor: 6.860

Review 9.  'Off-the-shelf' allogeneic CAR T cells: development and challenges.

Authors:  S Depil; P Duchateau; S A Grupp; G Mufti; L Poirot
Journal:  Nat Rev Drug Discov       Date:  2020-01-03       Impact factor: 84.694

Review 10.  Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.

Authors:  Anita D'Souza; Caitrin Fretham; Stephanie J Lee; Mukta Arora; Janet Brunner; Saurabh Chhabra; Steven Devine; Mary Eapen; Mehdi Hamadani; Parameswaran Hari; Marcelo C Pasquini; Waleska Perez; Rachel A Phelan; Marcie L Riches; J Douglas Rizzo; Wael Saber; Bronwen E Shaw; Stephen R Spellman; Patricia Steinert; Daniel J Weisdorf; Mary M Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-11       Impact factor: 5.609
View more
  2 in total

Review 1.  Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.

Authors:  Helen E Heslop; Edward A Stadtmauer; John E Levine; Karen K Ballen; Yi-Bin Chen; Amy E DeZern; Mary Eapen; Mehdi Hamadani; Betty K Hamilton; Parameswaran Hari; Richard J Jones; Brent R Logan; Leslie S Kean; Eric S Leifer; Frederick L Locke; Richard T Maziarz; Eneida R Nemecek; Marcelo Pasquini; Rachel Phelan; Marcie L Riches; Bronwen E Shaw; Mark C Walters; Amy Foley; Steven M Devine; Mary M Horowitz
Journal:  Transplant Cell Ther       Date:  2021-08-27

2.  Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.

Authors:  Betty K Hamilton; Corey Cutler; Clint Divine; Mark Juckett; Charles LeMaistre; Susan Stewart; Jennifer Wilder; Mary Horowitz; Nandita Khera; Linda J Burns
Journal:  Transplant Cell Ther       Date:  2022-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.